STERIGENICS DENMARK A/S: Financial statements 2017
CVR: 26299691
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
STERIGENICS DENMARK A/S (CVR 26299691) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 21,458,703 and a net result of DKK 12,106,970 compared with DKK 11,445,424 the year before. That is an increase of 22.5% compared with the year before. Equity in the 2017 report amounted to DKK 61,420,375. The solvency ratio was 83.1%.
- Gross Profit
- DKK 21,458,703
- Profit/Loss
- DKK 12,106,970
- Equity
- DKK 61,420,375
- Total Assets
- DKK 73,946,715
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 21.5 mio. | 12.1 mio. | 61.4 mio. | - |
| 2016 | - | 17.5 mio. | 11.4 mio. | 49.3 mio. | - |
| 2015 | - | 14.8 mio. | 9.2 mio. | 37.9 mio. | - |
| 2014 | - | 13.5 mio. | 4.1 mio. | 28.7 mio. | - |
| 2013 | - | 13.6 mio. | 5.2 mio. | 24.6 mio. | - |
Official annual report
Keep an eye on STERIGENICS DENMARK A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
STERIGENICS DENMARK A/S has published its annual report for 2016. Gross profit came to DKK 17,514,869, and the net result was DKK 11,445,424.
About STERIGENICS DENMARK A/S
STERIGENICS DENMARK A/S is a Danish company of the type Aktieselskab based in Espergærde, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named IBA S&I (DENMARK) A/S. The management consists of Maja Nøddekær. The board consists of Robin Van Der Bergh (chair), Maja Nøddekær and Ronald Victor Asselberghs. The company is owned by Nelson Labs BV. The company has 51 employees (2026). In 2025, the company reported a gross profit of DKK 45,023,268 and a net result of DKK 24,334,784 compared with DKK 25,507,602 the year before. Equity in the 2025 report amounted to DKK 44,335,784.
